These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 25764688)

  • 1. [Treatment strategy for the recurrence of HCV infection after liver transplantation in the era of DAA].
    Taketomi A
    Nihon Rinsho; 2015 Feb; 73(2):312-6. PubMed ID: 25764688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis C virus infection after liver transplantation.
    Agarwal K; Barnabas A
    Dig Liver Dis; 2013 Sep; 45 Suppl 5():S349-54. PubMed ID: 24091115
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of hepatitis C infection before and after liver transplantation.
    Fagiuoli S; Ravasio R; Lucà MG; Baldan A; Pecere S; Vitale A; Pasulo L
    World J Gastroenterol; 2015 Apr; 21(15):4447-56. PubMed ID: 25914454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C and liver transplantation.
    Martini S
    Minerva Gastroenterol Dietol; 2018 Jun; 64(2):158-169. PubMed ID: 28948755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents?
    Dall'Agata M; Gramenzi A; Biselli M; Bernardi M
    World J Gastroenterol; 2014 Jul; 20(28):9253-60. PubMed ID: 25071318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry.
    Belli LS; Perricone G; Adam R; Cortesi PA; Strazzabosco M; Facchetti R; Karam V; Salizzoni M; Andujar RL; Fondevila C; De Simone P; Morelli C; Fabregat-Prous J; Samuel D; Agarwaal K; Moreno Gonzales E; Charco R; Zieniewicz K; De Carlis L; Duvoux C;
    J Hepatol; 2018 Oct; 69(4):810-817. PubMed ID: 29940268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Directly acting antivirals (DAAs) for the treatment of chronic hepatitis C virus infection in liver transplant patients: "a flood of opportunity".
    Gane EJ; Agarwal K
    Am J Transplant; 2014 May; 14(5):994-1002. PubMed ID: 24730431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute cellular rejection in hepatitis C recipients following liver transplantation in the era of direct-acting antivirals: chronological analysis of the United Network for Organ Sharing database.
    Tanaka T; Voigt MD
    J Hepatobiliary Pancreat Sci; 2019 Sep; 26(9):393-400. PubMed ID: 31211912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New modalities in the treatment of HCV in pre and post - transplantation setting.
    Araz F; Durand CM; Gürakar A
    Turk J Gastroenterol; 2015 May; 26(3):204-13. PubMed ID: 26006192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent HCV after liver transplantation-mechanisms, assessment and therapy.
    Joshi D; Pinzani M; Carey I; Agarwal K
    Nat Rev Gastroenterol Hepatol; 2014 Dec; 11(12):710-21. PubMed ID: 25023032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved liver transplant waitlist mortality and lower risk of disease progression among chronic hepatitis C patients awaiting liver transplantation after the introduction of direct-acting antiviral therapies in the United States.
    Young K; Liu B; Bhuket T; Gish RG; Wong RJ
    J Viral Hepat; 2019 Mar; 26(3):350-361. PubMed ID: 30412318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreasing frequency and improved outcomes of hepatitis C-related liver transplantation in the era of direct-acting antivirals - a retrospective cohort study.
    Arora SS; Axley P; Ahmed Z; Satapathy SK; Wong R; Kuo YF; Singal AK
    Transpl Int; 2019 Aug; 32(8):854-864. PubMed ID: 30866110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of HCV transplant patients with triple therapy.
    Coilly A; Roche B; Duclos-Vallée JC; Samuel D
    Liver Int; 2014 Feb; 34 Suppl 1():46-52. PubMed ID: 24373078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment options in patients with decompensated cirrhosis, pre- and post-transplantation.
    Gambato M; Lens S; Navasa M; Forns X
    J Hepatol; 2014 Nov; 61(1 Suppl):S120-31. PubMed ID: 25443340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Considerations When Treating Hepatitis C in a Cirrhotic Transplant Candidate.
    Daniel KE; Said A
    Curr Gastroenterol Rep; 2018 Apr; 20(5):20. PubMed ID: 29623506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in.
    Price JC; Terrault NA
    Liver Transpl; 2015 Apr; 21(4):423-34. PubMed ID: 25604355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interferon-free regimens in the liver-transplant setting.
    Lens S; Gambato M; Londoño MC; Forns X
    Semin Liver Dis; 2014 Feb; 34(1):58-71. PubMed ID: 24782259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis viruses and liver transplantation: evolving trends in antiviral management.
    Verna EC
    Clin Liver Dis; 2014 Aug; 18(3):575-601. PubMed ID: 25017077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pleasant dilemma to have: to treat the HCV patient on the waiting list or to treat post-liver transplantation?
    Barsa JE; Branch AD; Schiano TD
    Clin Transplant; 2015 Oct; 29(10):859-65. PubMed ID: 26329668
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sofosbuvir and ribavirin prevent recurrence of HCV infection after liver transplantation: an open-label study.
    Curry MP; Forns X; Chung RT; Terrault NA; Brown R; Fenkel JM; Gordon F; O'Leary J; Kuo A; Schiano T; Everson G; Schiff E; Befeler A; Gane E; Saab S; McHutchison JG; Subramanian GM; Symonds WT; Denning J; McNair L; Arterburn S; Svarovskaia E; Moonka D; Afdhal N
    Gastroenterology; 2015 Jan; 148(1):100-107.e1. PubMed ID: 25261839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.